Lori M. Henderson - 13 May 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: General Counsel and Secretary
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 13 May 2021
Net transactions value: -$909,150
Form type: 4
Filing time: 14 May 2021, 16:04:31 UTC
Previous filing: 13 May 2021
Next filing: 20 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$98,010	+6,600	+733%	$14.85^*	7,501	13 May 2021	Direct	F1
transaction	MRNA	Common Stock	Sale	$1,007,160	-6,600	-88%	$152.60	901	13 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-6,600	-1.8%	$0.000000	354,752	13 May 2021	Common Stock	6,600	$14.85	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
F2	25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.